Trazodone for insomnia (sleep)
Trazodone is one of the most commonly prescribed sleep aids in the United States, yet it was never FDA-approved for insomnia — it's approved only to treat depression, and the doses used for sleep are far lower. Anyone taking it purely for sleep is getting an off-label prescription, and the formal evidence behind that practice is surprisingly thin. In fact, sleep-medicine specialists give a recommendation against using it for chronic insomnia, even though many clinicians still reach for it because it's cheap and non-habit-forming.
Is this an FDA-approved use?
No — this is off-label. Off-label means a clinician legally prescribes a drug for a condition the FDA never reviewed or approved it for. Trazodone's only FDA-approved use is major depressive disorder (MDD) in adults. As StatPearls puts it, trazodone 'is not FDA-approved for sleep disorders due to insufficient clinical data to justify its use as a sedative agent.' Off-label prescribing is legal and routine, but it means the sleep use was not vetted by the FDA the way a purpose-built sleeping pill was. To show how common this is: one analysis found roughly 85% of the ~24 million U.S. trazodone prescriptions in 2019 were off-label, primarily for insomnia. FDA-approved: The FDA approves trazodone only for major depressive disorder (MDD) in adults (initial U.S. approval 1981); its label carries no insomnia or sleep indication, so using it for sleep is off-label.
What the evidence actually shows
The catch is that the evidence trazodone actually helps chronic insomnia is limited. In its 2017 clinical practice guideline, the American Academy of Sleep Medicine (AASM) concluded: 'We suggest that clinicians not use trazodone as a treatment for sleep onset or sleep maintenance insomnia (versus no treatment) in adults,' and rated that recommendation WEAK. The guideline explains a weak recommendation reflects lower certainty in the evidence and 'should not be construed as an indication of ineffectiveness' — but it does mean the data are thin, drawn from few, mostly short trials with a risk of bias. Tellingly, the same guideline gave a weak recommendation FOR low-dose doxepin, another sedating antidepressant that IS FDA-approved for sleep — so 'it's an antidepressant that makes you drowsy' is not by itself proof it treats insomnia well. Trazodone stays popular for sleep more on clinical experience, low cost, and low dependence potential than on strong trial data.
How it's used off-label
For sleep, trazodone is prescribed at much lower doses than for depression — commonly 25–100 mg at bedtime, versus the 150–600 mg range used to treat major depression. StatPearls notes studies where '50 to 100 mg per day of trazodone helped nonorganic insomnia... with 100 mg dosage as the most effective to improve sleep.' The right dose — if any — is a decision for your prescriber based on your history, age, and other medications. This is background information, not a recommendation to start, stop, or change a dose on your own.
Risks and cautions
Key cautions: (1) Next-day grogginess — trazodone's sedation can linger into the morning; StatPearls lists 'headaches, fatigue, dizziness, drowsiness, and somnolence' among its primary adverse effects. (2) Orthostatic hypotension — the FDA label warns 'Hypotension, including orthostatic hypotension and syncope has been reported,' meaning blood pressure can drop on standing, a real fall risk in older adults. (3) Priapism — a rare but serious labeled warning: 'Cases of priapism (painful erections greater than 6 hours in duration) have been reported... Priapism, if not treated promptly, can result in irreversible damage to the erectile tissue.' The label says any erection lasting over 4 hours warrants stopping the drug and seeking emergency care. (4) Serotonin-related caution — trazodone is serotonergic, must not be combined with MAOIs (a 14-day washout is required), and can add to serotonin syndrome risk with other serotonergic drugs. Review every medication and supplement with a pharmacist or prescriber.
What’s actually FDA-approved for insomnia (sleep)
If you want options the FDA actually reviewed for insomnia, they include: the 'Z-drugs' zolpidem (Ambien), eszopiclone (Lunesta), and zaleplon (Sonata); low-dose doxepin (Silenor) for sleep maintenance; the melatonin-receptor agonist ramelteon (Rozerem); orexin-receptor antagonists such as suvorexant (Belsomra), lemborexant (Dayvigo), and daridorexant (Quviviq); and some benzodiazepines (temazepam, triazolam). Just as important, medication isn't step one: the American College of Physicians recommends that 'all adult patients receive cognitive behavioral therapy for insomnia (CBT-I) as the initial treatment for chronic insomnia disorder,' and the AASM likewise backs behavioral therapy as first-line. CBT-I matches sleeping pills short-term with fewer harms and more durable results. A clinician can help match an option to your situation.
Bottom line
Trazodone is cheap, non-scheduled, and hugely popular as an off-label sleep aid — but it's FDA-approved only for depression, and sleep specialists give a (weak) recommendation against it for chronic insomnia because the evidence is thin. It can still be a reasonable choice for some people, particularly those who also have depression, but CBT-I is the guideline-backed first step and there are FDA-approved sleep medicines if drugs are needed. Treat this as background and decide with a clinician, not on your own.
Frequently asked questions
Is trazodone a sleeping pill?
Not officially. Trazodone is an FDA-approved antidepressant for major depressive disorder, not an FDA-approved sleeping pill. It's prescribed off-label for insomnia because, at low doses, its blockade of histamine, serotonin-2A, and alpha-1 receptors is sedating — but the FDA never reviewed or approved it for sleep.
Is trazodone safe for sleep long-term?
The honest answer is that long-term data are limited — most studies were short, which is part of why the AASM gives a weak recommendation against it for chronic insomnia. It's not a controlled substance and has low dependence potential, but ongoing nightly use should be reviewed periodically with your prescriber, and CBT-I is the recommended first-line approach for chronic insomnia.
Trazodone vs Ambien (zolpidem) for sleep?
Zolpidem (Ambien) is FDA-approved for insomnia and the AASM gives it a weak recommendation for sleep-onset and maintenance; trazodone is off-label and gets a weak recommendation against. Zolpidem is a controlled substance with risks like complex sleep behaviors (sleep-driving); trazodone isn't scheduled but can cause next-day grogginess, orthostatic hypotension, and rarely priapism. Neither beats CBT-I as first-line — a prescriber weighs your specific situation.
Does trazodone cause dependence?
Trazodone is not a DEA-controlled substance and is generally considered to have low potential for dependence or abuse — one reason clinicians often prefer it over benzodiazepines or Z-drugs for sleep. That said, 'low' isn't 'none,' and stopping abruptly after long nightly use can cause discontinuation effects, so any changes should be made with a prescriber rather than cold-turkey.
How long before bed should I take trazodone?
Trazodone is sedating and is usually taken about 30 minutes to an hour before bedtime, since it's absorbed fairly quickly. Taking it too late, or at too high a dose, is a common cause of next-morning grogginess. Follow the specific timing and dose on your prescription — your prescriber sets these for your situation.
What is the usual trazodone dose for sleep?
For sleep, off-label doses are typically 25–100 mg at bedtime — much lower than the 150–600 mg used for depression. StatPearls cites studies where 50–100 mg helped insomnia, with 100 mg most effective. The right dose is set by your prescriber based on your history and other medications; don't self-adjust.
Sources
- Trazodone Hydrochloride — FDA label (DailyMed) ↗
- AASM 2017 Clinical Practice Guideline for the Pharmacologic Treatment of Chronic Insomnia in Adults (J Clin Sleep Med) ↗
- Trazodone — StatPearls (NCBI Bookshelf) ↗
- Management of Chronic Insomnia Disorder in Adults: A Clinical Practice Guideline (American College of Physicians, 2016) ↗
- Off-label policy through the lens of trazodone usage and spending in the United States (Health Affairs Scholar, 2025) ↗
More guides for Trazodone
More off-label uses: Propranolol for anxiety · Gabapentin for anxiety · Spironolactone for acne · Metformin for PCOS · Amitriptyline for insomnia.
This is general reference information, not medical advice. Off-label prescribing is legal and common, but whether a drug is right for you — on-label or off — is a decision for you and a licensed prescriber. Do not start, stop or change a medication based on this page.